Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

National Institute on Drug Abuse -  NIDA NOTES
Grants
Volume 12, Number 2
March/April 1997

NIDA Grant Announcements


NIDA has issued two new program announcements seeking proposals to study drug use, sexual risk behaviors, and HIV in men; and to conduct research on the health consequences of drug abuse.

Research grant applications are due on February 1, June 1, and October 1 each year. Deadlines for AIDS-related grant applications are January 2, May 1, and September 1 each year.

Copies of program announcements are available from NIDA's Grants Management Branch, 6001 Executive Blvd, Bethesda, Maryland 20892 , (301) 443-6710.

Program announcements and grant application forms may be obtained through NIDA's home page on the Internet's World Wide Web at http://www.nida.nih.gov by clicking on Funding Information. This information is also available from the National Institutes of Health (NIH) at (301) 435-0714 (hit option five) or through NIH's home page at http://www.nih.gov by clicking on Grants and Contracts.


Drug Use, Sexual Risk Behaviors, and HIV in Men (PA 96-074)

NIDA currently is supporting epidemiologic and HIV prevention studies on an especially high risk group: drug-using men who have sex with men (DU MSM). This announcement seeks to stimulate research on the interrelationship of HIV risk behaviors among DU MSM; causes and corresponding patterns of high risk; the efficacy and effectiveness of behavioral and biological HIV prevention interventions for diverse groups of DU MSM; and development and evaluation of new behavioral therapies, drug abuse treatment approaches, health services, and health care services delivery to DU MSM.

For information on programmatic and scientific issues involving epidemiologic and HIV prevention and intervention research, contact Dr. Richard H. Needle, NIDA, 6001 Executive Blvd, Bethesda, Maryland 20892 , (301) 443-6720. E-mail: rn28e@nih.gov. Questions about programmatic and scientific issues involving research in clinical/drug abuse treatment settings should be directed to Dr. Robert J. Battjes, NIDA, 6001 Executive Blvd, Bethesda, Maryland 20892 , (301) 443-6697. E-mail: rb97h@nih.gov.


Medical and Health Consequences of Drug Abuse (PA 96-010)

Drug abuse and drug-abusing behaviors have been linked to medical problems including infectious diseases, pulmonary disease, cardiac failure, and mental disorders.

NIDA is encouraging a wide range of studies on the factors, processes, and mechanisms associated with the onset, duration, clinical manifestations, and treatment of the mental and physical health consequences of drug use. Research may include general population-based, clinical epidemi-ologic, clinical, and laboratory studies addressing the morbidity and mortality of drug abuse. Parallel animal and human studies are encouraged.

For information on scientific and programmatic issues, contact Dr. Jag H. Khalsa, Division of Clinical and Services Research, NIDA, 6001 Executive Blvd, Bethesda, Maryland 20892 , (301) 443-1801. E-mail: jk98p@nih.gov.

From NIDA NOTES, March/April 1997


[NIDA Home Page][NIDA NOTES Index][1997 Archive Index Index]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal